Stay updated with breaking news from Graybug Vision Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MorphoSys (NASDAQ:MOR – Get Free Report) and Graybug Vision (NASDAQ:GRAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Valuation & Earnings This table compares MorphoSys and Graybug […]
/PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium...
Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report) shares dropped 2.3% during mid-day trading on Wednesday . The company traded as low as $2.15 and last traded at $2.15. Approximately 374 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 2,165 shares. The stock had previously closed at […]
International expansion of CARPO, a Phase 2b clinical trial of Auxora in acute pancreatitis patients with accompanying systemic inflammatory response syndrome , in India Expansion of team with key... -Today at 04:08 pm- MarketScreener
/PRNewswire/ -- Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases,...